Interatrial septal defect closure for prevention of cerebrovascular accidents: Impact on recurrence and frequency of migraine headaches

Journal of Invasive Cardiology

Volumn 19, Issue 6, 2007, Pages 257-260

  Shammas, Nicolas W ^a   Dippel, Eric J ^a   Harb, Ghassan ^a   Egts, Stephanie ^a   Jerin, Michael ^a   Stoakes, Penny ^a   Byrd, Jeannette ^a   Shammas, Gail A ^a   Sharis, Peter ^a  

^a MIDWEST CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ENOXAPARIN; HEPARIN; HIRULOG;

ADULT; AGED; ANTICOAGULATION; CARDIOMYOPATHY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DISABILITY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HEART EJECTION FRACTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE DISABILITY ASSESSMENT TEST; QUESTIONNAIRE; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW; SMOKING; STATISTICAL SIGNIFICANCE; TRANSIENT ISCHEMIC ATTACK;

CEREBROVASCULAR ACCIDENT; EMBOLISM, PARADOXICAL; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MIGRAINE DISORDERS; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 34249651224     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Wahl A, Meier B, Haxel B, et al. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology 2001;9:57:7.
2. Rodriguez CJ, Homma S. Management of patients with stroke and a patent foramen ovale. Current Neurol Neurosci Rep 2004;4:19-22.
3. Danzi GB, Sesanaa M, Capuano C, Baglini R. Percutaneous closure of patent foramen ovale: Pathophysiology, indications, and technique. Neurol Sci 2003;24(Suppl 1):S17-S19
4. Onorato E, Melzi G, Casilli F, et al. Patent foramen ovale with paradoxical embolism: Mid-term results of transcatheter closure in 256 patients. J Interv Cardiol 2003;16:43-50.
5. Martin F, Sanchez PL, Doherty E, et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002;106:1121-1126.
6. Braun MU, Fassbender D, Schoen SP, et al. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 2002;39:2019-2025.
7. Butera G, Bini MR, Chessa M, et al. Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke. Ital Heart J 2001;2:114-118.
8. Kondapaneni P. Does the percutaneous closure of patent foramen ovale help the migraine sufferer? Neurology 2004;27:62:8.
9. Schwedt TJ, Dodick DW. Patent foramen ovale and migraine - Bringing closure to the subject. Headache 2006;46:663-671.
10. Schwerzmann M, Wiher S, Nedeltchev K, Mattle HP, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004;62:1399-1401.
11. Azarbal B, Tobis J, Suh W, et al. Association of interatrial shunts and migraine headaches: Impact of transcatheter closure. J Am Coll Cardiol 2005;45:489-492.
12. Reisman M, Christofferson RD, Jesurum J, et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005;45:493-495.
13. Giardini A, Donti A, Formigari R, et al. Long-term efficacy of transcatheter patent foramen ovale closure on migraine headache with aura and recurrent stroke. Catheter Cardiovasc Interv 2006;67:625-629.
14. Sharifi M, Dehghani M, Mehdipour M, et al. Intense migraines secondary to percutaneous closure of atrial septal defects. J Interv Cardiol 2005;18:181-183.
15. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart 2005;91:1173-1175.
16. Wilmshurst P, Dowson A. Migraine Intervention with StarFlex Technology (MIST). Presented at the American College of Cardiology's 55th Annual Scientific Sessions, Late-Breaking Clinical Trials Sessions, Atlanta, March 11-14, 2006.